The FDA recently filed a permanent injunction halting operations at two Wisconsin drug firms from making or distributing its health care products. The action is against Triad Group Inc. and H & P Industries Inc. Both of the companies are managed and owned by the same individuals.
The Associated Press reports that federal prosecutors filed this legal injunction. Once the injunction is granted, the Court will prohibit the company from manufacturing and continuing regular operations until they show their practices meet federal quality standards.
In a recent Wall Street Journal article, Mia Lamar commented that if you call the phone number listed for H & P, the recording says the companies have “temporarily suspended operations.”
FDA’s associate commissioner for regulatory affairs commented in a release, saying, “This action is necessary to ensure that the companies operate in full compliance with federal quality standards and do not pose a risk to patients.”
H&P initiated five recalls of products since last year in December. These products have included alcohol-based skin wipes for rashes, sores and infections that have been caused by the products’ contamination. The products revealed to be a host to bacterial contamination. H&P has failed to comply with FDA regulations for several years now.
Triad Group initiated a major recall in December last year. The recall included 18 lots of sterile lubricating jelly as the sterility of the product was called into question. Approximately one month later, in January of this year, a death of a two year old boy led to the recall of more alcohol pads and swabs once it was discovered that the young boy was infected with bacillus cereus. This is a type of bacteria can be very harmful to humans., sometimes deadly.
If you have recently been affected by one of the recalled products, please review our website for more information. Our attorneys at Childers, Schlueter & Smith, LLC, have extensive knowledge of the Food and Drug Administration regulations, as well as product liability law. Contact Childers, Schlueter & Smith, LLC for more information or to get answers to any related questions you may have.
Other Triad News
The FDA seized $6 million in Triad Group products amid allegations of unsanitary manufacturing practices and shut down production.
The FDA shut down Triad Group’s drug production after contamination concerns and a child’s death linked to its products sparked lawsuits and a nationwide recall of alcohol wipes and swabs.
Patients using Copaxone for MS may face harmful side effects linked to contaminated Triad alcohol prep pads. Learn how legal action may help if you've been affected.
FDA inspections revealed 46 serious manufacturing violations at Triad Group—far above the norm—raising concerns about the safety of their medical products and potential harm to consumers.
Contaminated Triad alcohol wipes have been linked to serious infections and a child’s death, prompting lawsuits and FDA scrutiny. Learn your legal options if you’ve been affected.
